000 01311 a2200385 4500
005 20250515220455.0
264 0 _c20101102
008 201011s 0 0 eng d
022 _a1432-198X
024 7 _a10.1007/s00467-010-1515-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGhirardello, Stefano
245 0 0 _aRasburicase in the treatment of hyperuricemia of newborns.
_h[electronic resource]
260 _bPediatric nephrology (Berlin, Germany)
_cSep 2010
300 _a1775; author reply 1777 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aBiomarkers
_xblood
650 0 4 _aFemale
650 0 4 _aGestational Age
650 0 4 _aGout Suppressants
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHyperuricemia
_xblood
650 0 4 _aInfant, Low Birth Weight
650 0 4 _aInfant, Newborn
650 0 4 _aInfant, Premature
650 0 4 _aMale
650 0 4 _aTreatment Outcome
650 0 4 _aUrate Oxidase
_xtherapeutic use
650 0 4 _aUric Acid
_xblood
700 1 _aArdissino, Gianluigi
700 1 _aMastrangelo, Antonio
700 1 _aMosca, Fabio
773 0 _tPediatric nephrology (Berlin, Germany)
_gvol. 25
_gno. 9
_gp. 1775; author reply 1777
856 4 0 _uhttps://doi.org/10.1007/s00467-010-1515-0
_zAvailable from publisher's website
999 _c19735955
_d19735955